Eran Ophir

1.6k total citations
26 papers, 866 citations indexed

About

Eran Ophir is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Eran Ophir has authored 26 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 17 papers in Oncology and 4 papers in Hematology. Recurrent topics in Eran Ophir's work include CAR-T cell therapy research (12 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (11 papers). Eran Ophir is often cited by papers focused on CAR-T cell therapy research (12 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (11 papers). Eran Ophir collaborates with scholars based in Israel, United States and Switzerland. Eran Ophir's co-authors include Maya Koronyo‐Hamaoui, Michal Schwartz, Oleg Butovsky, Gilad Kunis, Hagit Cohen, Gennady Landa, Yaīr Reisner, Maya F. Kotturi, Drew M. Pardoll and Sudipto Ganguly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Eran Ophir

23 papers receiving 848 citations

Peers

Countries citing papers authored by Eran Ophir

Since Specialization

Citations

This map shows the geographic impact of Eran Ophir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eran Ophir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eran Ophir more than expected).

Fields of papers citing papers by Eran Ophir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eran Ophir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eran Ophir. The network helps show where Eran Ophir may publish in the future.

Co-authorship network of co-authors of Eran Ophir

This figure shows the co-authorship network connecting the top 25 collaborators of Eran Ophir. A scholar is included among the top collaborators of Eran Ophir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eran Ophir. Eran Ophir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preliminary antitumor activity of COM701 in combination with COM902 and pembrolizumab in patients with MSS-CRC and liver metastases. 2024 ·Journal of Clinical Oncology ·Manish Sharma, Anne M. Noonan, Daniel A. Vaena, Ecaterina E. Dumbrava, Judy S. Wang, Drew Rasco, Kyriakos P. Papadopoulos, Aditya Shreenivas, Pierre Ferré, Eran Ophir, (unknown), Gady Cojocaru, Michelle Mahler, Adeboye H. Adewoye, Manish R. Patel	1
2	550 Harnessing natural IL-18 activity through IL-18BP blockade reshapes the tumor microenvironment for potent anti-tumor immune response 2023 ·SHILAP Revista de lepidopterología ·(unknown), Zoya Alteber, Gady Cojocaru, (unknown), Dan Blat, (unknown), (unknown), Lital Sever, Nadav Cohen, Keren Cohen, Roy Z. Granit, (unknown), (unknown), (unknown), L. J. Soffer, (unknown), (unknown), (unknown), (unknown), Evgeny Tatirovsky, Pierre Ferré, Eran Ophir	0
3	Dominant Expression of PVRIG and TIGIT Inhibitory Pathways in Bone Marrow of Multiple Myeloma Patients 2021 ·Blood ·(unknown), Zoya Alteber, Ning Xu, Mingjie Li, Haiming Chen, Gady Cojocaru, James R. Berenson, Eran Ophir	0
4	COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade 2021 ·Cancer Immunology Immunotherapy ·Kyle Hansen, Sandeep Kumar, Kathryn Logronio, Sarah Whelan, (unknown), Hsin‐Yuan Cheng, (unknown), (unknown), Patrick D. Wall, (unknown), Ling Leung, Eran Ophir, Zoya Alteber, Gady Cojocaru, (unknown), (unknown), Mark A. White, John Hunter, Spencer C. Liang, Maya F. Kotturi	29
5	Therapeutic Targeting of Checkpoint Receptors within the DNAM1 Axis 2021 ·Cancer Discovery ·Zoya Alteber, Maya F. Kotturi, Sarah Whelan, Sudipto Ganguly, (unknown), Drew M. Pardoll, John Hunter, Eran Ophir	37
6	252 Novel DNAM-1 axis member, PVRIG, is potentially a dominant checkpoint involved in stem-like memory T cells – dendritic cell interaction 2021 ·SHILAP Revista de lepidopterología ·Zoya Alteber, Gady Cojocaru, (unknown), (unknown), Niv Sabath, (unknown), Amit Novik, Yossef Kliger, Zurit Levine, Eran Ophir	0
7	PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function 2019 ·Cancer Immunology Research ·Sarah Whelan, Eran Ophir, Maya F. Kotturi, Ofer Levy, Sudipto Ganguly, Ling Yan Leung, Ilan Vaknin, Sandeep Kumar, (unknown), Kyle Hansen, (unknown), (unknown), Abha Soni, Janis M. Taube, Amanda N. Fader, Tian‐Li Wang, Ie‐Ming Shih, Mark A. White, Drew M. Pardoll, Spencer C. Liang	125
8	Mouse PVRIG Has CD8+ T Cell–Specific Coinhibitory Functions and Dampens Antitumor Immunity 2019 ·Cancer Immunology Research ·(unknown), Xiaoyu Pan, Eran Ophir, Zoya Alteber, (unknown), Rupashree Sen, Ofer Levy, (unknown), Ilan Vaknin, (unknown), Ran Salomon, (unknown), Ada Tam, Doron Levin, (unknown), Evgeny Tatirovsky, Arthur Machlenkin, Drew M. Pardoll, Sudipto Ganguly	45
9	Personalized approaches to active immunotherapy in cancer 2015 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Eran Ophir, Sara Bobisse, George Coukos, Alexandre Harari, Lana E. Kandalaft	47
10	Autologous oxidized whole-tumor antigen vaccine in combination with angiogenesis blockade to elicit antitumor immune response in ovarian cancer. 2015 ·Journal of Clinical Oncology ·János L. Tanyi, Lana E. Kandalaft, Eran Ophir, (unknown), Raphaël Genolet, Emese Zsíros, Drew A. Torigian, Rosemarie Mick, (unknown), George Coukos	2
11	A new approach for eradication of residual lymphoma cells by host nonreactive anti–third-party central memory CD8 T cells 2013 ·Blood ·(unknown), Eran Ophir, (unknown), (unknown), Ran Afik, (unknown), Shlomit Reich-Zeliger, (unknown), Matthias Edinger, Robert S. Negrin, David Hagin, Yaīr Reisner	3
12	The use of donor-derived veto cells in hematopoietic stem cell transplantation 2012 ·Frontiers in Immunology ·Eran Ophir	11
13	Induction of transplantation tolerance in haploidenical transplantation under reduced intensity conditioning: The role of ex-vivo generated donor CD8+ T cells with central memory phenotype 2011 ·Best Practice & Research Clinical Haematology ·Eran Ophir, (unknown), (unknown), David Hagin, (unknown), (unknown), Yaīr Reisner	2
14	TCR-Independent Killing of B Cell Malignancies by Anti–Third-Party CTLs: The Critical Role of MHC–CD8 Engagement 2011 ·The Journal of Immunology ·(unknown), Polina Goichberg, (unknown), (unknown), Oren Milstein, Shraga Aviner, (unknown), Eran Ophir, Shlomit Reich-Zeliger, David Hagin, Tirza Klein, Arnon Nagler, Alain Berrébi, Yaīr Reisner	4
15	Ex Vivo Generated Donor Central Memory CD8 T Cells, Previously Shown to Enhance Engraftment of Allogeneic Bone Marrow, Also Exhibit Significant GVL Activity without Causing Gvhd In An In Vivo b Cell Lymphoma Model 2010 ·Blood ·(unknown), Eran Ophir, (unknown), (unknown), Ran Afik, (unknown), Robert S. Negrin, Arnon Nagler, Alain Berrébi, David Hagin, Yaīr Reisner	5
16	Induction of tolerance in organ recipients by hematopoietic stem cell transplantation 2009 ·International Immunopharmacology ·Eran Ophir, Yaīr Reisner	7
17	Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex vivo–induced central memory CD8 T cells 2009 ·Blood ·Eran Ophir, (unknown), Ran Afik, Esther Bachar-Lustig, Yaīr Reisner	22
18	Ex-Vivo Acquisition of Central Memory Phenotype Is Critical for Tolerance Induction by Donor Anti-3rd party CD8 T Cells in Allogeneic Bone Marrow Transplantation. 2008 ·Blood ·(unknown), Eran Ophir, Esther Bachar-Lustig, Ran Afik, Yaīr Reisner	4
19	The Structural Context of Disease-causing Mutations in Gap Junctions 2006 ·Journal of Biological Chemistry ·Sarel J. Fleishman, Adi D. Sabag, Eran Ophir, Karen B. Avraham, Nir Ben‐Tal	12
20	Glatiramer acetate fights against Alzheimer’s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1 2006 ·Proceedings of the National Academy of Sciences ·Oleg Butovsky, Maya Koronyo‐Hamaoui, Gilad Kunis, Eran Ophir, Gennady Landa, Hagit Cohen, Michal Schwartz	315

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact